about
The Experience Sampling Method--a new digital tool for momentary symptom assessment in IBS: an exploratory study.Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function.Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study.Does acute tryptophan depletion affect peripheral serotonin metabolism in the intestine?Ethanol impairs intestinal barrier function in humans through mitogen activated protein kinase signaling: a combined in vivo and in vitro approach.Time of ingestion relative to meal intake determines gastrointestinal responses to a plant sterol-containing yoghurt drink.Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome.Is microscopic colitis a drug-induced disease?Decreased levels of kynurenic acid in the intestinal mucosa of IBS patients: relation to serotonin and psychological state.Markers for visceral hypersensitivity in patients with irritable bowel syndrome.Capsaicin-induced satiety is associated with gastrointestinal distress but not with the release of satiety hormones.Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.Systematic review: instruments to assess abdominal pain in irritable bowel syndrome.Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel diseaseDoes Measurement of Esophagogastric Junction Distensibility by EndoFLIP Predict Therapy- responsiveness to Endoluminal Fundoplication in Patients With Gastroesophageal Reflux Disease?Measurement of Esophagogastric Junction Distensibility May Assist in Selecting Patients for Endoluminal Gastroesophageal Reflux Disease Surgery: Author's Reply.Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000 to 2012.Translational Difficulties in Studying the TRPA1 Receptor.Editorial: serotonin and irritable bowel syndrome--reconciling pharmacological effects with basic biology; authors' reply.Alterations in serotonin metabolism in the irritable bowel syndrome.Tricyclic Antidepressants: What to Choose and Which Dose?Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders.Social accountability in health professionals' training.Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism--a preliminary study.Does meal ingestion enhance sensitivity of visceroperception assessment in irritable bowel syndrome?An ileal brake-through?Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoffEffects of proton pump inhibitor therapy in the distal gut: putting the pieces togetherEsophagogastric junction distensibility in the management of achalasia patients: relation to treatment outcomeDilation in achalasia - is normal distensibility enough: Author's replyLetter: the role of sub-clinical inflammation and TRPV1 in the development of IBS-like symptoms in ulcerative colitis in remissionCapsaicin stimulation in irritable bowel syndrome: toward understanding visceral perception and pain symptom generationGut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndromeRole of TRPV1 and TRPA1 Ion Channels in Inflammatory Bowel Diseases: Potential Therapeutic Targets?Normal colonic transit time predicts the outcome of colonic manometry in patients with chronic constipation-an exploratory study
P50
Q33465409-B20E958F-046F-4666-A17C-871C9299F50EQ33489833-8BB37931-D1A3-4FD8-8006-997A478B88D3Q33735096-EE0A0B1F-8592-4C07-B4CD-C56B409476BAQ34149502-9EA45386-972D-4944-8B2B-7C8BE253089EQ34195561-EC7DE3A3-AF5A-4CFE-AAC4-78D497209068Q34390280-C3289A78-AB0A-4410-A039-73ADC93E2984Q34425563-7706C94E-D380-44DE-9995-11DF6720C95DQ34444085-2147380E-4720-4FB2-9F30-42781D425465Q34753910-70A84474-E38E-4194-B8DF-799B2F5DFB20Q35185813-D640FB6C-6E60-4925-AC6C-C70DBDD3697DQ35882148-A572D0D5-933F-4057-AE41-37B61760C1ECQ37293161-C5CB6E09-0436-400A-BA67-86DB56F3C793Q38569948-8A682269-EB6B-42F4-BA46-53CC18830FF0Q38660544-E10E3030-085C-47C5-A253-2FED56E8A63DQ39665612-C356B496-2F84-41FE-AD86-CED609F4F437Q41191329-D08E1376-306C-494B-8F37-DBC9CC7D16A7Q41748909-6EA1A44B-A0F2-4D81-8771-B0FD87361500Q42341384-72A77AFE-4353-4A13-979E-EEE5A603F8D1Q47835613-D3515A1B-044E-4ABD-A09C-D9BEB22A74CDQ47920570-BA9DA27A-6816-4F8B-BD9B-B0AF61DAE508Q48050479-87F4F984-2476-4811-97DF-FBC04C565722Q48270830-C7C67238-8F39-48F3-B1FD-831CC8B4DFE9Q48694742-5E0F68BF-2BBB-4534-A048-5E3B36E4AD7BQ50584030-8049EF05-E506-467E-953E-530C57E5C857Q51365874-D81C1E76-FC16-4DA9-A7DC-6506A3E6B2EFQ57124692-6C04658E-5F01-4CF2-96FD-7BAC3CF2A5A3Q84145763-1CEB47B2-23C1-448E-9319-50D60C1B512BQ84814571-C32EDCD3-1B1C-487B-944D-D67B489B6189Q85891027-35F7D818-B540-4A68-9535-59FA4961D307Q86950858-8BA2EF10-6B1A-410A-89CB-854DC89319A2Q87240346-98070FF1-609E-4019-AC31-28C23F5F58CEQ87499875-6422FF5D-1BFB-4F1C-A563-C95D8E6275EDQ90645881-243DCBB8-A907-4062-B64E-1EC14FE048EBQ92758175-AFFA7840-8E98-4CB3-811D-BEB79ED91476Q93024510-1F38DDAB-8B96-42D6-A10F-01AA7CCCE5E7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
D Keszthelyi
@ast
D Keszthelyi
@en
D Keszthelyi
@es
D Keszthelyi
@nl
D Keszthelyi
@sl
type
label
D Keszthelyi
@ast
D Keszthelyi
@en
D Keszthelyi
@es
D Keszthelyi
@nl
D Keszthelyi
@sl
prefLabel
D Keszthelyi
@ast
D Keszthelyi
@en
D Keszthelyi
@es
D Keszthelyi
@nl
D Keszthelyi
@sl
P106
P1153
15020799500
P31
P496
0000-0001-9856-9980